- How You Can Help Prevent Suicide During the COVID-19 Pandemic
- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
- Conspiracy Theories Are Helping Fuel Rejection of Masks, Vaccines
- U.S. Coronavirus Cases Top 7 Million
- Health Highlights: Sept. 25, 2020
- After COVID-19 Exposure, When Can Young Athletes Resume Play?
- Kids Who Need Steroids Face Risk of Diabetes, Other Ills
- COVID Bites: Cracked Teeth Another Coronavirus Scourge
Generic Effexor XR Approved
TUESDAY, June 29The first generic version of Effexor extended release capsules (venlafaxine hydrochloride) to treat major depressive disorder has been approved by the U.S. Food and Drug Administration.
Prescribing information for the generic version of Effexor XR may differ from that of the brand name drug because of various patents held by the brand name drug’s maker, Wyeth Pharmaceuticals, the FDA said in a news release. But the same safety warnings will apply.
The generic version will be manufactured by Teva Pharmaceuticals, based in Wales, Penn.
The drug’s label includes a warning that antidepressants may raise the risk of suicidal thoughts or tendencies among some children, teens and young adults, the agency said.
More information
To learn more about this drug, visit the U.S. National Library of Medicine.
Source: HealthDay
